Aaron C. Schmitt

Potent and selective Bruton’s tyrosine kinase inhibitors: Discovery of GDC-0834

Wendy B. Young, J A Barbosa, Peter Blomgren et al. · Bioorganic & Medicinal Chemistry Letters · 2015 · 65 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12

A convenient and high yield method to prepare 4-hydroxypyroglutamic acids

Xiaojun Zhang, Aaron C. Schmitt, Wen Jiang · Tetrahedron Letters · 2001 · 54 citations

Natural Sciences, Biochemistry, Chemistry +2

Discovery of Lanraplenib (GS-9876): A Once-Daily Spleen Tyrosine Kinase Inhibitor for Autoimmune Diseases

Peter Blomgren, Jayaraman Chandrasekhar, Julie A. Di Paolo et al. · ACS Medicinal Chemistry Letters · 2020 · 53 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13

Discovery of highly potent and selective Bruton’s tyrosine kinase inhibitors: Pyridazinone analogs with improved metabolic stability

Wendy B. Young, J A Barbosa, Peter Blomgren et al. · Bioorganic & Medicinal Chemistry Letters · 2015 · 41 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Discovery of Potent and Selective Tricyclic Inhibitors of Bruton’s Tyrosine Kinase with Improved Druglike Properties

Xiaojing Wang, J A Barbosa, Peter Blomgren et al. · ACS Medicinal Chemistry Letters · 2017 · 34 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15